Dihydroartemisinin Promotes N1 Polarization of Tumor-Associated Neutrophils and Enhances Their Anti-Tumor Activity via Hub Gene Modulation.

Wenjia Guo, Yu'e Liu, Wencong Ma, Jinghan Wang, Bingdi Chen, Lieying Fan

Abstract read

In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

The Therapeutic Potential of Dihydroartemisinin in Cancer Treatment.International journal of molecular sciences · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenjia GuoDepartment of Laboratory Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.ORCID 0000-0003-4746-0971

Yu'e LiuDepartment of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0009-0007-9516-5017

Wencong MaInstitute of Hepatobiliary and Pancreatic Surgery, Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

Jinghan WangInstitute of Hepatobiliary and Pancreatic Surgery, Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

Bingdi ChenThe Institute for Biomedical Engineering and Nano Science, School of Medicine, Tongji University, Shanghai 200092, China.ORCID 0000-0002-2086-0898

Lieying FanDepartment of Laboratory Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

Funding

Academic Leaders Training Program of Pudong Health Bureau of Shanghai PWRd2022-05Department of clinical laboratory medicine Shanghai East HospitalKey Discipline Construction Project Pudong Health Bureau of Shanghai PWZxk2022-02Scientific Research Project of Pudong New Area Science and Economic Commission PKJ2022-Y18

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dihydroartemisininmolecular dockingpolarizationtumor-associated neutrophils

Identifiers

PMID41599687

DOI10.3390/ph19010088

PMCPMC12844713

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.